Brivanib (alaninate)

TargetMol
Product Code: TAR-T2576
Supplier: TargetMol
CodeSizePrice
TAR-T2576-1mg1mg£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-2mg2mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-5mg5mg£164.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-1mL1 mL * 10 mM (in DMSO)£181.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-10mg10mg£239.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-25mg25mg£372.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-50mg50mg£562.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2576-100mg100mg£854.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.
CAS:
649735-63-7
Formula:
C22H24FN5O4
Molecular Weight:
441.46
Pathway:
Angiogenesis; Autophagy; Tyrosine Kinase/Adaptors
Purity:
0.9966
SMILES:
Cc1cc2c(ccc(c2F)Oc2c3c(C)c(cn3ncn2)OC[C@@H](C)OC(=O)[C@H](C)N)[nH]1
Target:
VEGFR; FGFR; Autophagy

References

1. Bhide RS, et al. J Med Chem, 2006, 49(7), 2143-2146. 2. Huynh H, et al. Clin Cancer Res, 2008, 14(19), 6146-6153. 3. Cai ZW, et al. J Med Chem, 2008 , 51(6), 1976-1980. 4. Ayers M, et al. Cancer Res, 2007, 67(14), 6899-6906.